Pilot Trial of XFBD, a TCM, in Persons With COVID-19

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
The purpose of this study is to document the safety of taking traditional Chinese medicine (TCM) in patients with COVID-19 and to gain information to determine whether a study with TCM can be conducted. The study will test a traditional Chinese medicine that has been made into a granule formulation called Xuanfei Baidu Granules.
Epistemonikos ID: f3318d5696a213856b27dce2f30a046b47dfcd2b
First added on: Mar 24, 2021